Express Scripts revenue surged in the three months through September, even as speculation mounted that the Trump administration will try to revamp a key piece of its business model.

Sales at the pharmacy benefit manager, which earlier this year won federal approval for its merger with Cigna, grew to $25.6 billion. Profit rose 27 percent to $1.1 billion, or $1.89 a share.